14445-75-1

Usage

Uses

Used in Medicinal Chemistry:
1,3,5-Triazine, 2,4,6-tri-1H-imidazol-1-ylis used as a building block in medicinal chemistry for its potential to interact with biological targets due to the presence of imidazole groups. This interaction capability makes it a candidate for the development of new pharmaceuticals with specific therapeutic effects.
Used in Drug Development:
In the field of drug development, 1,3,5-Triazine, 2,4,6-tri-1H-imidazol-1-ylis utilized as a starting point for the creation of novel therapeutic agents. The triazine ring's chemical properties provide a foundation for further modifications, which can improve the compound's biological activity and drug-like characteristics, leading to the discovery of new medications.
Used in Chemical Modifications:
1,3,5-Triazine, 2,4,6-tri-1H-imidazol-1-ylis employed as a substrate for chemical modifications aimed at enhancing its biological activity and drug-like properties. The triazine ring can be altered to create derivatives with improved pharmacokinetics, pharmacodynamics, and safety profiles, which are essential for successful drug development.
Used in Research and Exploration:
1,3,5-Triazine, 2,4,6-tri-1H-imidazol-1-ylis also used in research and exploration to uncover its full potential in various applications. Further studies on 1,3,5-Triazine, 2,4,6-tri-1H-imidazol-1-ylmay reveal additional uses in different areas of pharmaceuticals and medicine, expanding its utility and impact on healthcare.

Upstream product

• 288-32-4 1H-imidazole 
• 108-77-0 1,3,5-trichloro-2,4,6-triazine 

Relevant academic research and scientific papers

Supramolecular porous ionic network based on triazinonide and imidazolium: A template-free synthesis of meso-/macroporous organic materials: Via a one-pot reaction-assembly procedure

A supramolecular porous ionic network (SPIN-1) was designed and prepared using a one-pot procedure, involving the quaternization of triimidazole triazine with cyanuric chloride followed by hydrolysis and in situ assembly. The structure of SPIN-1 was characterized by FT-IR, solid-state 13C CP/TOSS NMR, elemental analysis and XPS. SPIN-1 shows a BET surface area up to 263 m2 g-1 (average pore size 11 nm), and a CO2 capture capacity of 24.7 cm3 g-1, which is competitive for Carbon Capture and Storage (CCS).

A bifunctional cationic porous organic polymer based on a Salen-(Al) metalloligand for the cycloaddition of carbon dioxide to produce cyclic carbonates

A bifunctional cationic porous organic polymer based on a Salen-(Al) metalloligand (Al-CPOP) containing imidazolium functionality exhibited enhanced activity and good recyclability in the cycloaddition of carbon dioxide to produce cyclic carbonates without the addition of co-catalysts at atmospheric pressure.

A convenient method for the preparation of some new derivatives of 1,3,5-s-triazine under solvent free condition

Nucleophilic reactions on cyanuric chloride were carried out under solvent free conditions to give 1,3,5-s-triazine derivatives with excellent yields.

2,4,6-tris(azol-1-yl)-1,3,5-triazines: A new class of multidentate ligands

The synthesis of thirteen tris(azol-1-yl)-s-triazines (azole = pyrazoles, imidazoles, 1,2,4-triazole and benzimidazoles) is described. Particularly interesting are the compounds derived from C-adamantylazoles (4-adamantylpyrazole, 2-adamantylimidazole and